No. Stage 2 describes the situation in which the COVID-19 pandemic has put increased clinical demands on the institution. Programs at institutions in Stage 2 are governed by the Common and specialty-specific Program Requirements, as well as variances addressed on the ACGME website for “Stage 2: Increased Clinical Demands.” The ACGME expects organizations in Stage 2 to follow that guidance for program changes to meet increasing patient needs.
Institutions that are in Stage 3 and declare Pandemic Emergency Status must notify the Institutional Review Committee, but notification of the ACGME or Review Committees regarding Stage 2 status is not required, nor is there any need to provide an update to the Review Committee after 30 days. Programs should, however, provide a brief description of program changes in response to the pandemic in the Major Changes and Other Updates section in the Accreditation Data System (ADS) during the next Annual Update.